Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Amgen
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
Amgen 20060332 : Essai de phase 1-2 évaluant l'efficacité et la tolérance d'un traitement associant le panitumumab à l'AMG655, chez des patients ayant un cancer colorectal métastatique. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A Phase 1b/2 Trial of AMG 655 in Combination With Panitumumab in Subjects With Metastatic Colorectal Cancer.
Country
France
organs
Côlon ou Rectum (colorectal)
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Estudio aleatorizado, multicéntrico, de fase 3 para comparar la eficacia de panitumumab combinado con oxaliplatino/5-fluorouracilo/leucovorina con la eficacia de oxaliplatino/5-fluorouracilo/leucovorina solos en pacientes con cáncer colorrectal metastásico no tratado previamente
Evaluar si panitumumab combinado con quimioterapia de 5-fluorouracilo, leucovorina y oxaliplatino (FOLFOX) en infusión mejora la supervivencia libre de progresión (SLP) en comparación con FOLFOX solo ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Estudio abierto de extensión de fase 2 con conatumumab . A Phase 2 Open Label Extension Study of Conatumumab
Continuar ofreciendo un tratamiento con terapia de conatumumab, con o sin quimioterapia (incluyendo bevacizumab) o con o sin AMG 479, para pacientes que reúnen los requisitos de participación, de acue...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
Amgen 20060159 : Essai de phase 2 randomisé, en double aveugle, évaluant l’efficacité et la tolérance d’un traitement associant sorafénib et AMG386 chez des patients ayant un cancer du rein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A randomized, double blinded, multi-center phase 2 study to estimate the efficacy and evaluate the safety and tolerability of sorafenib in combination with AMG 386 or placebo in subjects with metastat...
Country
France
organs
Rein
Specialty
Chimiothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A clinical study to assess the safety and efficacy of AMG 145 on low density cholesterol in subjects with homozygous familial hypercholesterolemia or PCSK9 mutations
To characterize the safety and tolerability of long-term administration of AMG 145 among patients with severe familial hypercholesterolemia
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Study of Evolocumab in Patients Undergoing Low-Density Lipoprotein Apheresis Estudio de evolocumab para pacientes sometidos a aféresis del C-LDL
To evaluate the efficacy of subcutaneous (SC) evolocumab, compared to regularly scheduled LDL-C apheresis, on reducing the need for future apheresis. Evaluar la eficacia de evolocumab administra...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
The trial is designed to determine the long-term safety and efficacy of ABP 501 in subjects with moderate to severe rheumatoid arthritis
The primary objective is to evaluate the long-term safety and efficacy of ABP 501 in subjects with moderate to severe rheumatoid arthritis.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
Amgen 20060362 : Essai de phase 2 randomisé évaluant l'efficacité de l'AGM479 associé à de l'exemestane ou à du fulvestrant, chez des patientes ménopausées ayant un cancer du sein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
An international, randomized, double-Blind, placebo-Controlled, phase 2 Study of AMG 479 with exemestane or fulvestrant in postmenopausal women with hormone receptor positive locally advanced or metas...
Country
France
organs
Sein
Specialty
Thérapies Ciblées
,
Hormonothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
KAI Pharmaceuticals, Inc. (a subsidiary of Amgen, Inc.)
Update Il y a 4 ans
A study of AMG 416 in the treatment of secondary hyperparathyroidism in chronic kidney disease
To characterize the long-term safety and tolerability of AMG 416 in the treatment of SHPT in subjects with CKD on hemodialysis.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A study of talimogene laherparepvec in pediatric subjects with tumors that are able to be directly injected and do not occur in the spinal cord or brain
To determine the safety and tolerability of talimogene laherparepvec, as assessed by incidence of dose-limiting toxicities (DLT), in pediatric subjects with advanced non central nervous system (CNS) t...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
2
3
4
5
6
7
8
9
10
11
Next